Residency · Residency · General Surgery

Acute Cholecystitis and Biliary Emergencies

Overview

Biliary emergencies encompass acute cholecystitis, choledocholithiasis, ascending cholangitis, and gallstone pancreatitis. The general surgery resident must be proficient in the diagnosis, severity grading, and management of these conditions, including appropriate timing of surgical intervention and the recognition of life-threatening complications.

Gallstone Disease Fundamentals

Epidemiology

Gallstones affect 10 to 15% of the adult population in Western countries. Risk factors include female sex, age over 40, obesity, rapid weight loss, pregnancy, TPN use, Native American and Hispanic ethnicity, cirrhosis, and hemolytic disorders. Despite the high prevalence of gallstones, only about 20% of carriers ever become symptomatic.

Types of Gallstones

Cholesterol stones account for approximately 80% of gallstones in Western populations and form through a combination of bile supersaturation with cholesterol, nucleation, and gallbladder hypomotility. Pigment stones come in two varieties: black pigment stones, composed of calcium bilirubinate and associated with hemolytic disorders, cirrhosis, and TPN; and brown pigment stones, which are associated with biliary infection and stasis, are more common in Asian populations, and frequently form within the bile ducts themselves.

Biliary Colic

Biliary colic results from intermittent obstruction of the cystic duct by a stone. Despite the name, the pain is actually steady rather than truly colicky, localized to the right upper quadrant or epigastrium, lasting 30 minutes to several hours, and often occurring postprandially -- especially after fatty meals. Crucially, biliary colic is distinguished from cholecystitis by the absence of fever, leukocytosis, or persistent tenderness. Ultrasound demonstrates cholelithiasis without gallbladder wall thickening or pericholecystic fluid. Management is elective laparoscopic cholecystectomy.

Acute Cholecystitis

Pathophysiology

Acute cholecystitis develops when sustained cystic duct obstruction leads to gallbladder distension, wall edema, and inflammation. The process is initially a chemical or sterile inflammation, with secondary bacterial infection occurring in 20 to 75% of cases. Common organisms include E. coli, Klebsiella, Enterococcus, and Bacteroides. The disease follows a predictable progression from edematous to suppurative to gangrenous cholecystitis, ultimately leading to perforation if untreated.

Diagnosis

The clinical presentation includes right upper quadrant pain lasting more than 6 hours, fever, the Murphy sign (inspiratory arrest during RUQ palpation), and right upper quadrant guarding. Laboratory studies typically show leukocytosis. Mildly elevated liver function tests may be present, but significant elevation should raise concern for choledocholithiasis or Mirizzi syndrome.

Ultrasound is the first-line imaging study. Key findings include gallstones (sensitivity 95%), gallbladder wall thickening greater than 4 mm, pericholecystic fluid, the sonographic Murphy sign (the most specific finding when performed by an experienced operator), and gallbladder distension (greater than 10 cm long or 5 cm transverse). When ultrasound is equivocal, a HIDA scan is indicated: non-visualization of the gallbladder at 4 hours after radiotracer injection confirms cystic duct obstruction with a sensitivity of 97% and specificity of 90%.

Tokyo Guidelines Severity Grading

The Tokyo Guidelines (TG18/TG13) classify acute cholecystitis into three grades.

Grade I (mild) describes acute cholecystitis without organ dysfunction or severe local inflammation. Grade II (moderate) is characterized by elevated WBC above 18,000, a palpable RUQ mass, symptom duration exceeding 72 hours, or marked local inflammation including gangrenous cholecystitis, pericholecystic abscess, biliary peritonitis, or emphysematous cholecystitis. Grade III (severe) involves organ dysfunction -- cardiovascular, neurologic, respiratory, renal, hepatic, or hematologic.

Management

Laparoscopic Cholecystectomy

Laparoscopic cholecystectomy is the standard of care for acute cholecystitis. Timing is critical: early cholecystectomy, performed within 72 hours and ideally within 24 hours of admission, is preferred over delayed surgery. The ACDC trial demonstrated that early cholecystectomy reduces morbidity, hospital stay, and cost. The guiding principle is "the earlier, the better," as outcomes worsen with increasing delay.

The Critical View of Safety (CVS) is the most important technical concept in cholecystectomy. It requires identification of exactly two structures -- the cystic duct and the cystic artery -- entering the gallbladder, with the hepatocystic triangle completely cleared of fat and fibrous tissue. When the CVS cannot be achieved, bail-out procedures must be employed: subtotal cholecystectomy (fundus-first, leaving the posterior wall on the liver bed -- either reconstituting or fenestrating), cholecystostomy tube placement, conversion to open cholecystectomy, or simply stopping to call for help and considering alternatives.

Percutaneous Cholecystostomy

Percutaneous cholecystostomy is indicated for patients too unstable for surgery (Grade III). It allows drainage and clinical stabilization, with the tube typically left in situ for 30 days. Interval cholecystectomy can be considered after recovery. However, the CHOCOLATE trial showed that laparoscopic cholecystectomy was superior to percutaneous drainage even in high-risk patients.

Acalculous Cholecystitis

Acalculous cholecystitis accounts for 5 to 10% of acute cholecystitis cases and occurs in critically ill, ICU, TPN-dependent, burn, or immunocompromised patients. The pathogenesis involves gallbladder stasis and ischemia. Diagnosis relies on ultrasound (wall thickening, distension, and pericholecystic fluid without stones) and HIDA scanning. The condition carries a high perforation and gangrene rate of 40 to 60%. Treatment is percutaneous cholecystostomy for critically ill patients, with cholecystectomy performed when feasible.

Choledocholithiasis

Risk Stratification

The ASGE/SAGES guidelines stratify patients into three risk categories.

High risk (greater than 50% probability of CBD stone) is defined by a CBD stone visible on imaging, clinical ascending cholangitis, or a total bilirubin exceeding 4 mg/dL with a dilated CBD. Intermediate risk includes patients with abnormal liver function tests (other than bilirubin above 4), a dilated CBD on ultrasound (greater than 6 mm with gallbladder in situ), or age over 55. Low risk patients have normal LFTs, no dilated CBD, and no clinical predictors.

Management by Risk

High-risk patients should undergo preoperative ERCP with sphincterotomy and stone extraction, followed by laparoscopic cholecystectomy. Intermediate-risk patients should have the diagnosis confirmed with MRCP or endoscopic ultrasound (EUS), proceeding to ERCP if positive; alternatively, an intraoperative cholangiogram can be performed with laparoscopic CBD exploration if stones are found. Low-risk patients proceed directly to laparoscopic cholecystectomy, with intraoperative cholangiogram at the surgeon's discretion.

Intraoperative Cholangiogram

The intraoperative cholangiogram identifies unsuspected CBD stones in 3 to 5% of cases and delineates biliary anatomy, which may help prevent bile duct injury (though this remains debated). The technique involves partial clipping of the cystic duct, insertion of a cholangiocatheter, and injection of contrast under fluoroscopy.

Laparoscopic Common Bile Duct Exploration

When CBD stones are found, laparoscopic exploration can be performed via a transcystic approach (for small distal stones, using basket or balloon extraction) or through a choledochotomy (for large or multiple stones, or when the transcystic approach fails). Stone clearance rates are comparable to ERCP at over 90%, with the advantage of single-stage management.

Ascending Cholangitis

Charcot Triad and Reynolds Pentad

The Charcot triad -- fever, jaundice, and right upper quadrant pain -- is present in 50 to 70% of cholangitis cases. The Reynolds pentad adds altered mental status and hypotension to the Charcot triad, indicating severe or suppurative cholangitis, and is present in only 5 to 7% of cases.

Tokyo Guidelines Severity

Grade I (mild) cholangitis responds to initial medical therapy. Grade II (moderate) does not respond to initial therapy but involves no organ dysfunction, requiring early biliary drainage. Grade III (severe) involves organ dysfunction and requires emergent biliary drainage with ICU care.

Management

Initial management includes IV fluid resuscitation and broad-spectrum antibiotics covering gram-negatives and anaerobes (piperacillin-tazobactam or meropenem plus vancomycin). Biliary drainage is the definitive treatment. ERCP with sphincterotomy is first-line, with a success rate exceeding 90%. Percutaneous transhepatic cholangiography and drainage (PTC) is used when ERCP fails or is unavailable, and surgical common bile duct exploration is a last resort. Timing depends on severity: Grade III requires emergent drainage within 12 to 24 hours, Grade II within 24 to 48 hours, and Grade I can be semi-elective. Cholecystectomy should follow after resolution of the acute episode, ideally during the same admission.

Gallstone Pancreatitis

Gallstones are the third most common cause of acute pancreatitis after alcohol and idiopathic causes. A stone transiently impacted at the ampulla causes pancreatic duct obstruction. Diagnosis requires elevated lipase (greater than 3 times the upper limit of normal) with gallstones visible on imaging. An ALT exceeding 150 IU/L has an 85% positive predictive value for gallstone etiology.

Management includes supportive care for pancreatitis (IV fluids, pain management, and bowel rest as needed). Cholecystectomy during the index admission, after clinical improvement, is essential to prevent recurrence, which occurs in 25 to 30% of patients within 6 weeks if cholecystectomy is not performed. ERCP within 24 hours is indicated if concurrent cholangitis or persistent biliary obstruction is present. An intraoperative cholangiogram at the time of cholecystectomy evaluates for residual CBD stones.

Mirizzi Syndrome

Mirizzi syndrome involves extrinsic compression of the common hepatic duct by a stone impacted in the cystic duct or Hartmann pouch. It is classified into four types:

Type I involves extrinsic compression only; Type II involves a cholecystobiliary fistula affecting less than one-third of the CBD circumference; Type III involves a fistula affecting one-third to two-thirds of the CBD; and Type IV involves a fistula affecting more than two-thirds of the CBD or complete destruction. Preoperative recognition is critical to avoid bile duct injury. Management consists of partial cholecystectomy for Type I and biliary reconstruction (Roux-en-Y hepaticojejunostomy) for Types III and IV.

<image>Ultrasound findings in acute cholecystitis showing a distended gallbladder with wall thickening greater than 4mm, pericholecystic fluid, and an impacted stone in the gallbladder neck. Include a comparison panel showing normal gallbladder ultrasound appearance with thin wall and clear pericholecystic space. Label the gallbladder wall layers, stones with posterior acoustic shadowing, and measurement annotations.</image>

<image>Anatomical illustration demonstrating the Critical View of Safety (CVS) during laparoscopic cholecystectomy. Show the hepatocystic triangle cleared of fat and fibrous tissue with only two structures (cystic duct and cystic artery) entering the gallbladder, and the lower third of the gallbladder separated from the liver bed. Include a companion diagram showing a dangerous misidentification of the common bile duct as the cystic duct to illustrate why the CVS is essential.</image>

<image>Flowchart diagram for the management of suspected choledocholithiasis based on ASGE risk stratification. Show three pathways: low risk (proceed to cholecystectomy with optional IOC), intermediate risk (MRCP or EUS, then ERCP if positive), and high risk (preoperative ERCP then cholecystectomy). Include decision points for cholangitis requiring emergent biliary drainage.</image>

Clinical Pearls

The Murphy sign is the single most useful physical examination finding for acute cholecystitis, but it is absent in gangrenous cholecystitis due to denervation of the gallbladder wall. The critical view of safety is the most important step in preventing bile duct injury during cholecystectomy -- no structure should be clipped or cut unless it is definitively identified. If the critical view of safety cannot be achieved, a bail-out strategy must be used: subtotal cholecystectomy, cholecystostomy tube, or conversion to open. Early cholecystectomy within 72 hours for acute cholecystitis is safe and associated with shorter total hospital stay -- as the adage goes, "the sun should not set twice on acute cholecystitis." An ALT exceeding 150 IU/L in the setting of pancreatitis has an 85% positive predictive value for gallstone etiology. Cholecystectomy should be performed during the index admission for gallstone pancreatitis to prevent recurrent episodes. The Reynolds pentad (Charcot triad plus hypotension and altered mental status) indicates suppurative cholangitis requiring emergent biliary drainage. Mirizzi syndrome should be suspected when preoperative imaging shows a stone impacted in the gallbladder neck with proximal biliary dilation and a normal-caliber distal CBD.

References

• Yokoe M, Hata J, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25(1):41-54.
• Strasberg SM. Clinical practice. Acute calculous cholecystitis. N Engl J Med. 2008;358(26):2804-2811.
• Buxbaum JL, Abbas Fehmi SM, Sultan S, et al. ASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasis. Gastrointest Endosc. 2019;89(6):1075-1105.
• Gurusamy KS, Davidson C, Gluud C, Davidson BR. Early versus delayed laparoscopic cholecystectomy for people with acute cholecystitis. Cochrane Database Syst Rev. 2013;(6):CD005440.

Read this lecture as Markdown